Header Logo

Connection

SPYRIDOULA VASILEIOU to Lymphoma

Back to Details
This is a "connection" page, showing publications SPYRIDOULA VASILEIOU has written about Lymphoma.
SPYRIDOULA VASILEIOU
Connection Strength
0.420
Lymphoma
  1. T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects. J Clin Oncol. 2021 05 01; 39(13):1415-1425.
    View in: PubMed
    Score: 0.420
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.